Medical Device Veteran Urges Shift to Practical Innovation
July 28, 2026 — David Ferrera, CEO of RC Medical, urges medical device innovators to prioritize practicality and workflow over novelty to improve stroke care and patient outcomes.
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
July 28, 2026 — David Ferrera, CEO of RC Medical, urges medical device innovators to prioritize practicality and workflow over novelty to improve stroke care and patient outcomes.
July 27, 2026 — GeoVax Labs reports Q2 2026 financial results and advances GEO-MVA pivotal immunobridging study for mpox/smallpox vaccine. Also progressing Gedeptin immuno-oncology program. Learn more.
July 27, 2026 — VERAXA Biotech advances bispecific ADC program VXA-222 with OmniAb, using AND-gate technology to target solid tumors. Learn how this collaboration aims to improve precision cancer therapy.
July 27, 2026 — Quantum BioPharma (QNTM) features Lucid-MS for MS and unbuzzd product in BioMedWire Podcast. Learn about Phase 2 trial plans and commercial strategy.
July 27, 2026 — Onco-Innovations advances ONC010 manufacturing, partners with Nanosoft Polymers, Nucro-Technics, and Avance Clinical to target cancer resistance via DNA repair inhibition.
July 27, 2026 — Regentis Biomaterials (RGNT) targets $3B cartilage repair market with GelrinC, an off-the-shelf regenerative platform simplifying knee cartilage repair via a 10-minute procedure.
July 27, 2026 — Earth Science Tech (ETST) reports FY2026 results with 8% revenue growth to $35.7M, 11% net income increase. CEO highlights integrated telemedicine-to-pharmacy model. Learn more.
July 27, 2026 — Traditional Navajo medically tailored meals reduce heart failure hospitalizations by over half in landmark clinical trial by American Heart Association and The Rockefeller Foundation.
July 27, 2026 — Experimental immunotherapy shows promise against deadly pediatric brain cancer, with research in Nature Medicine highlighting new hope. CNS Pharmaceuticals also advances treatments.
July 27, 2026 — VERAXA Biotech (VRXA) shareholders approve capital band, board expansion, and warrant issuance with 99.94% vote. The measures support BiTAC(R) platform and oncology pipeline growth.
July 27, 2026 — Tonix Pharmaceuticals to report Q2 2026 financial results and operational highlights on Aug. 10, 2026. Flagship fibromyalgia drug TONMYA and pipeline updates highlight company's CNS and immunology focus.
July 27, 2026 — VERAXA Biotech (VRXA) and OmniAb (OABI) advance VXA-222 bispecific ADC program targeting solid tumors with precision AND-gate approach. Key milestone achieved in collaboration.
July 27, 2026 — Onco-Innovations (ONCO, ONNVF) combines PNKP inhibitor ONC010, nanoparticle delivery, and AI from Inka Health to tackle cancer drug resistance, trial failures, and toxicity. Read more.
July 27, 2026 — CME conference in Denver offers up to 26 credits for nurse practitioners, PAs, RNs, and physicians. Expert speakers cover cardiology, orthopedics, and more. Earn credits and improve patient care.
July 27, 2026 — ADAP Advocacy urges moving 340B Drug Pricing Program oversight from HRSA to CMS to enforce transparency and ensure revenues benefit low-income patients. Learn about the proposed reform.
July 25, 2026 — Scottsdale Detox coordinates with sister facility The Hope House to close care gaps between detox and rehab, reducing relapse risk. Personalized care with private rooms and executive suites.
July 25, 2026 — Scottsdale TMS Therapy introduces Spravato esketamine nasal spray paired with TMS for treatment-resistant depression, offering fast symptom relief within days. Learn about this innovative clinic.
July 25, 2026 — Arizona IOP launches flexible scheduling for working professionals, allowing device use during recovery. Get intensive outpatient care without career disruption.
July 25, 2026 — The Hope House luxury rehab now verified through Cigna, Aetna, and UMR. Low-density, personalized care in Scottsdale mansions. Call (480) 448-6087.
July 25, 2026 — Review reveals CHD proteins CHD7, CHD4, CHD8 have distinct roles in heart development, offering new insights into congenital heart defects and improving genetic screening priorities.